Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Doxorubicin Plus Carboplatin vs Carboplatin in Recurrent Ovarian Cancer
NCT00043082Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Aug 2002
- Primary completion
- Jun 2007
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of pegylated liposomal doxorubicin in ovarian cancer, primary peritoneal cancer (PPC), sponsored by SWOG Cancer Research Network. Started Aug 2002; status: completed.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00043082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043082.